Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

Walgreens Boots Alliance / Equity Bottom-Up

<ul><li>Walgreens Boots Alliance reported its Fourth Quarter FY 2024 results amidst significant strategic and operational shifts.</li><li>The quarter was marked by a mix of achievements and challenges, aligning with their previously stated objectives of cost cutting, CapEx reduction, and improvements in working capital, all contributing to a positive cash flow in the quarter.</li><li>Baptista Research looks to evaluate the different factors that could influence the company's price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.</li></ul>

Walgreens Boots Alliance reported its Fourth Quarter FY 2024 results amidst significant strategic and operational shifts.The quarter was marked by a mix of achievements and challenges, aligning with their previously stated objectives of cost cutting, CapEx reduction, and improvements in working capital, all contributing to a positive cash flow in the quarter.Baptista Research looks to evaluate the different factors that could influence the company's price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

Walgreens Boots Alliance Inc.: Capital Discipline & Store Optimization To Orchestrate A Turnaround? - Major Drivers

Pan-Asia Catalysts/Events, Quiddity Advisors

Travis Lundy

Pan-Asia Catalysts/Events

Quiddity Advisors

Index Rebalance

Apollo Global Management  / Index Rebalance

<ul>
<li>The S&amp;P 500 index tracks the 500 largest names listed in the US and it is one of the most highly-tracked indices in the world.</li>
<li>In this insight, we take a look at the upcoming constituent changes in the run up to the December 2024 index rebal event.</li>
<li>We expect two regular changes in December 2024. There are also several live spin-off and M&amp;A events which could trigger intra-review index changes in the late-2024/early-2025.</li>
</ul>


The S&amp;P 500 index tracks the 500 largest names listed in the US and it is one of the most highly-tracked indices in the world.
In this insight, we take a look at the upcoming constituent changes in the run up to the December 2024 index rebal event.
We expect two regular changes in December 2024. There are also several live spin-off and M&amp;A events which could trigger intra-review index changes in the late-2024/early-2025.


Quiddity Leaderboard S&P 500 Dec 24: Two ADDs (One Biggie), Two DELs, Possible Big Intrareview Moves

AI and Global Deep Tech, Mint Finance

Uttkarsh Kohli

AI and Global Deep Tech

Deep Fundamental Analysis

Mint Finance

Mint Finance's investment research blends deep fundamental analysis with technical & quant insights. Investment strategies straddle across multiple asset classes with risk management embedded into every trade to deliver an outsized reward-to-risk ratio.

Mint Finance's research is centered around three key themes. First, energy transition and climate change. Second, artificial intelligence. Third, shifting world order with its impact across politics and monetary economics.

<ul>
<li>SMCI has surged 214% YTD and will form part of NASDAQ-100 from 22/Jul topping $50 billion in valuation. Strategic partnerships with Nvidia &amp; AMD boosted its AI server market presence. </li>
<li>Walgreens has declined 56% YTD with its market cap falling below $10 billion. Failing to maintain at least 0.1% of NASDAQ 100’s market value has led to its exclusion. </li>
<li>Historically, stocks added to indices outperformed briefly post-announcement. Although recent trend shows minimal outperformance, SMCI and WBA have shown strong trends due to idiosyncratic drivers.</li>
</ul>


SMCI has surged 214% YTD and will form part of NASDAQ-100 from 22/Jul topping $50 billion in valuation. Strategic partnerships with Nvidia &amp; AMD boosted its AI server market presence. 
Walgreens has declined 56% YTD with its market cap falling below $10 billion. Failing to maintain at least 0.1% of NASDAQ 100’s market value has led to its exclusion. 
Historically, stocks added to indices outperformed briefly post-announcement. Although recent trend shows minimal outperformance, SMCI and WBA have shown strong trends due to idiosyncratic drivers.


Super Micro Ascends, Walgreens Exits Nasdaq-100 on 22/Jul. How Will Index Rebalancing Pan Out?

<ul><li>Walgreens Boots Alliance recently reported on its performance for the third quarter of Fiscal Year 2024.</li><li>The results presented in this discussion reflect mixed outcomes in various areas of the company’s businesses.</li><li>It is essential to provide a comprehensive view of the positive developments as well as the drawbacks evident in the quarter under review.</li></ul>

Walgreens Boots Alliance recently reported on its performance for the third quarter of Fiscal Year 2024.The results presented in this discussion reflect mixed outcomes in various areas of the company’s businesses.It is essential to provide a comprehensive view of the positive developments as well as the drawbacks evident in the quarter under review.

Walgreens Boots Alliance: Enhancing Digital & Operational Efficiency To Expand Margins! - Major Drivers

<ul><li>The Walgreens Boots Alliance's latest earnings revealed that the company's second-quarter operational results aligned with expectations despite ongoing challenges in the U.S. retail environment.</li><li>The company reported an adjusted EPS of $1.20, reflecting discipline in cost and good execution in the U.S. Retail Pharmacy segment, along with solid performance internationally.</li><li>Baptista Research looks to evaluate the different factors that could influence the company's price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.</li></ul>

The Walgreens Boots Alliance's latest earnings revealed that the company's second-quarter operational results aligned with expectations despite ongoing challenges in the U.S. retail environment.The company reported an adjusted EPS of $1.20, reflecting discipline in cost and good execution in the U.S. Retail Pharmacy segment, along with solid performance internationally.Baptista Research looks to evaluate the different factors that could influence the company's price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

Walgreens Boots Alliance Inc.: Redefining Relationships & Creating Value with Payers! - Major Drivers

United States

Walgreens Boots Alliance, Inc., operates retail drugstores that offer a wide variety of prescription and non-prescription drugs as well as general goods. Walgreens' also offers health services, including primary and acute care, wellness, pharmacy and disease management services and health and fitness.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Walgreens Boots Alliance (WBA US)

Walgreens Boots Alliance Inc.: Capital Discipline & Store Optimization To Orchestrate A Turnaround? - Major Drivers

Walgreens Boots Alliance reported its Fourth Quarter FY 2024 results amidst significant strategic and operational shifts. The quarter was marked...

Baptista Research

Quiddity Leaderboard S&P 500 Dec 24: Two ADDs (One Biggie), Two DELs, Possible Big Intrareview Moves

There are currently two expected ADDs and two expected DELs for the SP500 Dec24 Rebalance. There could be more from spinoffs and mergers. One big...

Travis Lundy

Super Micro Ascends, Walgreens Exits Nasdaq-100 on 22/Jul. How Will Index Rebalancing Pan Out?

NASDAQ index will rebalance admitting SMCI replacing WBA. SMCI has surged 214% YTD while WBA has crumbled 56% YTD. Index effect posits for SMCI to...

Mint Finance

Walgreens Boots Alliance: Enhancing Digital & Operational Efficiency To Expand Margins! - Major Drivers

Walgreens Boots Alliance recently reported on its performance for the third quarter of Fiscal Year 2024. The results presented in this discussion...

Baptista Research

Walgreens Boots Alliance Inc.: Redefining Relationships & Creating Value with Payers! - Major Drivers

The Walgreens Boots Alliance's latest earnings revealed that the company's second-quarter operational results aligned with expectations despite...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)